Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2015 Jan 20;8:34. doi: 10.1186/s13071-014-0622-3

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© Wheeler et al.; licensee BioMed Central. 2015

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

PMC Copyright notice

RNAi phenotypes correlate to pharmacology screen. A) Comparative pharmacology led to the selection of ARPC2 (increased motility) and NDUFV2 (no noticeable phenotype) as proof of principle targets for RNAi-mediated knock-down. RNAi of both targets did not bring about any significant changes in planarian motility. However, ARPC2 suppression was lethal to regenerating G. tigrina. These observations correlate to the pharmacology screen where no phenotype was observed with application of NDUFV2 inhibitor, but stark motility phenotypes were observed with ARPC2 chemical inhibitor. B) Survival curves show significantly decreased (P < 0.0001; Log-rank Mantel-Cox test) rates of survival for ARPC2(RNAi) cut worms in comparison to control cut worms. C) Prior to death, caudal fragments of ARPC2(RNAi) cut worms showed impaired sealing of the initial wound and improper blastema formation. Proper eye spot formation can be observed in control worms (red arrows) and is absent in the ARPC2 suppressed worms. These experiments were carried out in duplicate, with at least 10 whole planaria used for motility assays and 20 planarian halves used to monitor regeneration.